Phreesia, Inc. (NYSE:PHR) Receives Average Recommendation of “Buy” from Brokerages

Phreesia, Inc. (NYSE:PHR) has been given a consensus rating of “Buy” by the twelve research firms that are covering the firm, Marketbeat.com reports. Twelve research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have covered the stock in the last year is $31.00.

PHR has been the subject of several analyst reports. Truist Financial boosted their price objective on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Citigroup boosted their price objective on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. KeyCorp boosted their price objective on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and upped their target price for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Finally, Robert W. Baird cut their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th.

Insider Buying and Selling at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 3,495 shares of the company’s stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $24.88, for a total value of $86,955.60. Following the transaction, the general counsel now owns 116,296 shares of the company’s stock, valued at approximately $2,893,444.48. This represents a 2.92 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Balaji Gandhi sold 5,827 shares of the business’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total transaction of $159,135.37. Following the sale, the chief financial officer now directly owns 141,846 shares in the company, valued at approximately $3,873,814.26. This trade represents a 3.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 131,756 shares of company stock valued at $3,244,909. Corporate insiders own 5.80% of the company’s stock.

Institutional Trading of Phreesia

Several large investors have recently added to or reduced their stakes in PHR. Deerfield Management Company L.P. Series C acquired a new stake in Phreesia during the 2nd quarter valued at $4,078,000. Champlain Investment Partners LLC raised its stake in Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after purchasing an additional 97,847 shares during the period. Sei Investments Co. raised its stake in Phreesia by 135.3% during the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after purchasing an additional 95,058 shares during the period. Squarepoint Ops LLC raised its stake in Phreesia by 56.3% during the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after purchasing an additional 90,215 shares during the period. Finally, State Street Corp raised its stake in Phreesia by 7.1% during the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares during the period. 92.10% of the stock is owned by institutional investors and hedge funds.

Phreesia Stock Performance

Shares of PHR stock opened at $27.29 on Thursday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The business has a 50 day moving average of $23.77 and a two-hundred day moving average of $22.94. Phreesia has a 52 week low of $17.07 and a 52 week high of $29.16. The company has a market cap of $1.59 billion, a P/E ratio of -18.56 and a beta of 0.94.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business’s revenue was up 16.6% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.58) earnings per share. As a group, analysts anticipate that Phreesia will post -1.1 EPS for the current year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.